Linda J. Bendall

Medicine · Health Sciences

37h-index10.4kcitations133works9.22yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Lymphoblastic Leukemia research(31), Hematopoietic Stem Cell Transplantation(26), Chronic Lymphocytic Leukemia Research(26), Chemokine receptors and signaling(22), PI3K/AKT/mTOR signaling in cancer(17)

Publications127 total

Data from A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
2023Open Access
Supplementary material and methods, Tables 1-3 from A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
2023Open Access
Supplementary Figure 1 from A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
2023Open Access
Supplementary material and methods, Tables 1-3 from A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
2023Open Access
Supplementary Figure 2 from A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
2023Open Access
Supplementary Figure 2 from A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
2023Open Access
Data from A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
2023Open Access
Supplementary Figure 1 from A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
2023Open Access
Data from Sphingosine Kinase 2 Promotes Acute Lymphoblastic Leukemia by Enhancing <i>MYC</i> Expression
2023Open Access
Data from Sphingosine Kinase 2 Promotes Acute Lymphoblastic Leukemia by Enhancing <i>MYC</i> Expression
2023Open Access
Supplementary Methods, Figures 1 - 14, Tables 1 - 5 from Sphingosine Kinase 2 Promotes Acute Lymphoblastic Leukemia by Enhancing <i>MYC</i> Expression
2023Open Access
Supplementary Methods, Figures 1 - 14, Tables 1 - 5 from Sphingosine Kinase 2 Promotes Acute Lymphoblastic Leukemia by Enhancing <i>MYC</i> Expression
2023Open Access
Bone Marrow Graft-Versus-Host Disease in Reduced Intensity Conditioned Major Histocompatibility Complex Matched Murine Allogeneic Hematopoietic Cell Transplantation
Transplantation·2018
Sphingosine kinase 2 supports the development of BCR/ABL-independent acute lymphoblastic leukemia in mice
Biomarker Research·2018· 5 citedOpen Access
Bone Marrow Graft-Versus-Host Disease in Reduced Intensity Conditioned Major Histocompatibility Complex Matched Murine Allogeneic Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation·2018Open Access
Identification of sphingosine kinase 1 as a therapeutic target in B‐lineage acute lymphoblastic leukaemia
British Journal of Haematology·2018· 15 citedOpen Access
Regulation of the bone marrow microenvironment by G-CSF: Effects of G-CSF on acute lymphoblastic leukaemia
PLoS ONE·2017· 2 citedOpen Access
Therapeutic targeting of a9b1 and a4b1 integrins for chemosensitization of drug resistant acute leukaemia
Experimental Hematology·2017
Bone Marrow Graft-Versus-Host Disease in Major Histocompatibility Complex-Matched Murine Reduced-Intensity Allogeneic Hemopoietic Cell Transplantation
Transplantation·2017· 3 cited
Extracellular molecules in hematopoietic stem cell mobilisation
International Journal of Hematology·2016· 15 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Kenneth F. Bradstock(22), Julius Juaréz(9), Rana Baraz(8), Adam Cisterne(7), John Hewson(6), Paul J. Simmons(4), Jean-Pierre Lévesque(4), James S. Wiley(4), David Gottlieb(4), Marilyn Thien(4), Robert Welschinger(4), Aileen Dela Peňa(4), Craig T. Wallington‐Beddoe(4), Jordan Basnett(4), Ben J. Gu(3), K. F. Bradstock(3), Naveed I. Khan(3), Roman Crazzolara(3), Sonia Saad(3), Philip O. Saunders(3)